share_log

华邦健康(002004.SZ):在合成生物方面暂未涉及相关产品

Huabang Health (002004.SZ): No related products are involved in synthetic biology

Gelonghui Finance ·  May 9 19:45

Gelonghui, May 10 | Huabang Health (002004.SZ) said on the investor interactive platform that in terms of synthetic biology, the company has not yet involved related products, but the company will actively experiment with synthetic biology technology and keep a close eye on related policy developments. In terms of stem cells, the company's shareholders are involved in related businesses: 1. Hebei Life Origin Biotechnology Co., Ltd. is the builder and operator of the Hebei Stem Cell Bank. Its core business is cell storage business such as neonatal stem cells, adult immune cells, etc., and clinical research and application transformation of stem cell products. 2. Jiangsu Puxin Biomedical Co., Ltd. is mainly engaged in the CDMO business for cell and gene therapy drugs. It has built a dedicated plasmid construction platform for cellular drugs, a production platform for suspended serum-free viruses, and a fully enclosed cell process development platform. It has supported many partners to successfully incubate various drugs such as CAR-T, TCR-T, stem cells, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment